Fimepinostat - An Overview
A stage I review in Japanese individuals with R/R NHL, together with ATLL sufferers, confirmed a workable safety profile, and 40 mg 2 times per week was selected for subsequent medical enhancement.These preclinical observations help the speculation that tucidinostat will likely be efficacious in ATLL.Cleanrooms and managed environments are useful